Beckman Coulter acquires genetic analysis technology.(Executive briefing: news, trends & market intelligence for instrument executives)(Brief Article)

From: Instrument Business Outlook | Date: September 15, 2003 | Copyright information

Fullerton, CA 9/10/03 -- Beckman Coulter has acquired the proprietary technologies of Peoples Genetics for an undisclosed amount. Peoples Genetics' technologies are made up of procedures for sample preparation and constant denaturant capillary electrophoresis that can be applied to large pools of DNA (up to 100,000 samples) for identification and validation of low-frequency mutations. Beckman Coulter plans to integrate this technology into its current genetic analysis platform, starting with the company's CEQ 8000 genetic analysis system. "This combined solution can remove a ...

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Beckman Buys Peoples Genetics' Technologies.
; Beckman Coulter, Inc. (4300 N. Harbor...the technologies of Peoples Genetics, Inc. (PGI, 6-C Gill...University, will be joining Beckman Coulter as consultants. Emphasizing...feasible and practical. Beckman Coulter initially plans to...
BECKMAN COULTER.(Brief Article)
; BECKMAN COULTER: has filed a $500 million shelf registration with the US Securities and Exchange Commission.
Beckman Coulter and Applera reach settlement.(Executive Briefing: News, Trends & Market Intelligence for Instrument Executives)
; ...Fullerton, CA and Norwalk, CT 4/26/06--Beckman Coulter and Applera announced the establishment...litigation between the companies. In 2002, Beckman Coulter filed suit against Applera, alleging...IBO 9/15/05). Under the settlement, Beckman Coulter will grant royalty bearing licenses...
BECKMAN COULTER/BIO-RAD NOT TO RENEW ACCESS SALES CONTRACT.(Beckman Coulter Inc. will not renew contract with Bio-Rad Laboratories Inc.)(Brief Article)
; Beckman Coulter, Inc (NYSE:BEC), Fullerton, Calif...and the Pacific Rim. As a result, Beckman Coulter assumes sales responsibility for...allergy and diabetes. In 1997, Beckman Coulter, then Beckman Instruments, Inc...
Beckman Coulter introduces asset management program.(INDUSTRY/REGULATORY NEWS)
; BECKMAN COULTER has announced the introduction of...service program. With the program, Beckman Coulter assumes service ownership and maintenance...customers with a dedicated, onsite Beckman Coulter team who manages and schedules all...
Beckman Coulter to acquire Agencourt Bioscience for $100 million.(Executive Briefing: News, Trends & Market Intelligence for Instrument Executives)
; Fullerton, CA and Beverly, MA 4/27/05 -- Beckman Coulter has announced plans to acquire Agencourt...DNA. As a wholly-owned subsidiary of Beckman Coulter, Agencourt will become a Beckman Coulter center of excellence for nucleic acid...
Beckman Coulter, Inc.(Brief Article)(Company Profile)
; Beckman Coulter, Inc. simplifies and automates laboratory...the hospital clinical laboratory, Beckman Coulter's products perform virtually all...analysis and robotic automation. Beckman Coulter's customers include pharmaceutical...
Beckman Coulter expands chemistry offerings.(Executive Briefing: News, Trends & Market Intelligence for Instrument Executives)
; Fullerton, CA 10/2/06 -- Beckman Coulter has agreed to acquire Lumigen...chemiluminescent substrate to Beckman Coulter for use with its immunoassay...Research and Development for Beckman Coulter's Immunoassay business. Beckman...
Beckman Coulter, Inc. Laboratory Automation Operations. (Web Site Tour).
; ...beckmancoulterlims.com Company Name: Beckman Coulter, Inc. Laboratory Automation Operations...Laboratory Automation Operations (LAO) of Beckman Coulter includes a comprehensive explanation...of interest. Users can learn about Beckman Coulter's 20+ years of data management ...
Beckman Coulter.(buys from Avocet Medical)(Brief Article)
; Beckman Coulter, Fullerton, Calif., acquired a point...The $3 million transaction gives Beckman Coulter all rights to Avocet's patented...undergoing anti-coagulation therapy. Beckman Coulter plans to market the system mainly...